Experienced Leadership. Proven Execution.
Galenicap is led by a seasoned team of industry experts with experience across more than 100 drug formulation programs and a strong track record in advancing therapies through Phase I and II clinical development.
Hans Platteeuw
Executive Director & Chief Development Officer
Sandy Verhaegen
Chief Operating Officer
​
Erik Grimmelickhuysen
SPV Lead
Aclathera BV
%202_edited.jpg)
Bertine Vorstenbosch
Regulatory Affairs
​
Laurens G. Theunis
Executive Director & Chief Executive Officer
Mike Foorer
Business Development
​
Bernd van Buuren
SPV Lead
Glicothera BV​
Cindy Dieteren
Project
Management
Donald Kalff
Non-Executive Director
​
Carolin Schwartner-Lehr
Business Development
​
Hans Van der Steen
SPV Lead
Clozathera BV
Daria Alekseeva
Project
Management
Maarten Pouw
Chief Commercial Officer
​
Yvonne van Rijswick
Clinical Development
​​
Jan Wit
Product & CMC Development
Marek Cichocki
Project
Management
Join us
We are building a team focused on transforming proven science into better therapies and meaningful clinical impact. Our work sits at the intersection of innovation and execution, addressing unmet medical needs through a disciplined and hands-on approach.
​
At Galenicap, you will be part of a dynamic and collaborative environment where scientific insight, entrepreneurial thinking, and practical execution come together. We are always interested in connecting with individuals who are driven by impact and motivated to contribute to the development of differentiated therapies.
Project Managers (Clinical)
Selected candidates will be responsible for the preparation and implemenation of clinical development programs
Project Manager (Development)
Selected candidates will be responsible for the design and implementation of drug formulation and CMC development projects
Apply now!
We are always looking for great talent. Give us a call or send us your resume! Contact
​